, which is an assessment that is in concert with systematic reviews (9, 10).
INTRODUCTION
Prostate cancer is one of the most frequent cancers in men in developed countries, and in 2009, 4299 cases of prostate cancer were reported to the Cancer Registry of Norway, and 1048 patients died of the disease (1) .
In vitro and animal studies have indicated that vitamin D may have anticancer effects, including protection against progression and metastasis in a wide spectrum of cancers (2) . Vitamin D is hydroxylated to 25- (4) , and may respond to 1,25(OH) 2 D with increased differentiation and apoptosis and decreased proliferation, invasiveness, and metastasis (2, 5) . However, it is unclear whether these effects, observed in vitro, translate into decreased risk of prostate cancer in men (2) . It has been observed that prostate cancer cells have a reduced 1-a-hydroxylase activity, which might result in a reduced local production of 1,25(OH) 2 D (2, 3).
Two decades ago, Schwartz et al (6) hypothesized that vitamin D deficiency might increase risk of prostate cancer, and numerous studies have later assessed this relation. Two recent meta-analyses concluded that there is no consistent relation between serum 25(OH)D [s-25(OH)D] and prostate cancer (7, 8) , which is an assessment that is in concert with systematic reviews (9, 10) .
However, in a Nordic study from 2004, both high and low s-25(OH)D concentrations were associated with increased risk of prostate cancer (11) . In a large American nested case-control study, higher s-25(OH)D concentrations were associated with increased risk of aggressive prostate cancer (12) . Men with high s-25(OH)D were also recently observed to have elevated risk of prostate cancer in a large Finnish study, in which the association seemed to be strongest for aggressive disease (13) . Recently, a Swedish study also observed a positive association between 25(OH)D and prostate cancer (14) , whereas a recent British study did not (15) .
The main objective of the current study, which included 2106 patients with prostate cancer and 2106 matched control subjects, was to assess the prospective relation between s-25(OH)D and risk of prostate cancer. Because it has been suggested that high concentrations of retinol may antagonize the effect of vitamin D on cancer (2, 13), we aimed to investigate whether serum retinol interacted on any relation between s-25(OH)D and prostate cancer risk. In addition, a priori, we specified separate analyses according to the stage of disease at diagnosis, time between blood sampling and cancer diagnosis, age at diagnosis, year of diagnosis, and season of serum sampling.
SUBJECTS AND METHODS

Study population and endpoint
We used data from population-based standardized cardiovascular health surveys carried out in 17 of Norway's 19 counties between 1981 and 1991, which represented both urban and rural areas. All screenings were conducted by the National Health Screening Service (now part of the Norwegian Institute of Public Health), except for in Oslo, where it was conducted by the local health authority. In the surveys, men and women in a selected birth cohort who were residing in the counties were invited to participate. The median participation rate in these surveys was 71% (range: 55-88%) for men. The health examination included the measurement of height, weight, and blood pressure and questionnaire data that included the history and symptoms of cardiovascular disease, physical activity, and smoking history. A nonfasting blood sample was drawn for analyses of blood lipids. Residual serum was stored at -25 8 C in the Janus Serum Bank, which was established in 1973. The serum bank includes serum samples from .330,000 healthy donors (http://www.kreftregisteret. no/en/Research/Janus-Serum Bank/). Several stability studies have been performed to describe the quality and usefulness of serum in the Janus Serum Bank (16) .
In the current study, we linked data on men who participated in the health surveys and had serum in the Janus Serum Bank to the Cancer Registry of Norway to prospectively register new cases of prostate cancer throughout 2006. It was a prerequisite that cancer cases had to have donated serum $1 y before diagnosis, and 2282 men were diagnosed with prostate cancer during follow-up. Of these men, 156 cases had a previous cancer and were omitted, which left 2126 cases for analyses. For each case, one control was selected who was matched for age at serum sampling (66 mo), date of serum sampling (62 mo), and county of residence (ie, health examination). Controls were alive and free from cancer at the time the corresponding case received the cancer diagnosis. Because of missing data, 15 persons were excluded. Furthermore, 5 of the selected controls had a benign diagnosis that changed status to malignant during the period of selection of controls (International Classification of Diseases-7 code 195.3). Thus, these matched pairs were omitted, which left 2106 case-control pairs (4212 men) for the primary analysis. On the basis of information on metastases at the time of diagnosis, cases were categorized into one of the following 3 stage groups: localized stage (invasive cancer without any metastases), advanced stage (any infiltration into surrounding structures; regional or distant metastases), and unknown stage (the status of metastasis was unknown). Aliquots of a large collection of human plasma were used as between-run quality control. The assay is accredited by the Vitamin D External Quality Assessment Scheme. All case-control pairs were analyzed within the same batch. Plasma retinol was determined at Vitas by using HPLC-UV. One hundred microliters of plasma was diluted with 450 mL 2-propanol that contained retinyl propionate as an internal standard and butylated hydroxytoluene as an antioxidant. After thorough mixing (15 min) and centrifugation (10 min; 4000 3 g at 10 8 C), an aliquot of 20 mL was injected from the supernatant fluid into the HPLC system. HPLC was performed with an HP 1100 liquid chromatograph with an HP1100 diode array detector (Agilent Technologies). Retinoids were separated at 40 o C on a Chromolith SpeedROD RP-18e (Merck Millipore) 4.6 3 50-mm reverse-phase column. A linear gradient was generated from mobile phase A (1:9 vol:vol H 2 O: MeOH) and mobile phase B (65:35 vol:vol 2-propanol-MeOH). A 3-point calibration curve was made from the analysis of an MeOH solution enriched with known retinol concentrations. Recovery was .97%; the method was linear at least from 0.1 to 10 mmol/L, and the detection limit was 0.22 pmol. The percentage of CV was 4.8%.
Examinations
Data on education were received from Statistics Norway, and on the basis of the Norwegian Standard Classification of Education, they were divided into 3 levels as follows: primary, secondary, and university or college. BMI (in kg/m 2 ; weight divided by the square of height) was calculated on the basis of measured heights and weights from health surveys. The physical activity during leisure time was assessed by using a question graded from 1 to 4 (sedentary, moderate, intermediate, and intensive, respectively). Current cigarette smoking was assigned for subjects who responded that they currently smoked cigarettes daily.
In a small number of the case-control pairs, data were missing for some covariates, which left 2093 pairs with complete data on education, 2088 pairs with complete data on physical activity, 2084 pairs with complete data on BMI, and 2089 pairs with complete data on smoking. All data linkages were done by using the unique Norwegian 11-digit personal identification code.
Before the study started, we calculated that 1100 case-control pairs would give the study .95% power at a 5% significance level to detect an OR of 1.4 for the lowest quartile compared with the upper 3 quartiles of 25(OH)D.
Statistical analyses
Baseline characteristics were compared by using a paired t test for continuous variables and McNemar's test for categorical variables because of the matched nature of the data set. Conditional logistical regression models were used to assess the relation between s-25(OH)D and cancer risk, estimating that the rate ratio (RR) as the collection of controls was done by risk-set sampling (17) . Similarly, we assessed the relation between serum retinol and cancer risk. To explore any interaction between s-25(OH)D and serum retinol on risk of prostate cancer, we included an interaction term with both as continuous variables. Interactions were assessed by the log-likelihood ratio test, and P , 0.05 was considered statistically significant. In addition to crude analyses, 25(OH)D concentrations were adjusted for the month of serum sampling to control for any residual difference in season between cases and controls and for the possible confounders education, physical activity, BMI, and smoking.
As in the previous Nordic study (11) , the season of blood sampling was defined as winter (December through . Therefore, before performing season-specific analyses, we collapsed the groups to winter and spring (December through May) and summer and autumn (June through November). These analyses were also done by using conditional logistic regression, and as a consequence, matched case-control pairs examined in different seasons were omitted.
According to a North-South gradient of UV exposure, we grouped Norwegian counties into 3 regions: southern region (Rogaland, Vest-Agder, Aust-Agder, Telemark, Oslo, Akershus, Vestfold, Østfold, Oppland, and Hedmark), middle region (Sogn og Fjordane, Møre og Romsdal, and Sør-Trøndelag), and northern region (Nord-Trøndelag, Nordland, Troms, and Finnmark).
A priori, we categorized s-25(OH)D into 5 groups as follows: ,30, 30-49, 50-69, 70-89, and $90 nmol/L. In addition, we ran s-25(OH)D as a continuous variable. Similarly, retinol was categorized in quintiles on the basis of the retinol distribution in controls. Data were analyzed with PASW Statistics 17.0 (IBM Corporation) and STATA version 11.1 software (StataCorp LP).
Ethics
The study was approved by the Regional Committee for Medical Research Ethics of Western Norway.
RESULTS
The mean age at screening was 48.2 y in cases and controls ( Table 1 ). The great majority of subjects belonged to the age groups 40-55 y (82.5%) and 65-67 y (16.4%). Educational status was somewhat higher in cases than controls, whereas there were no significant differences in BMI, physical activity during leisure time, or current cigarette smoking.
The median time from screening to prostate cancer diagnosis was 16.1 y and was ,10 y in 14%, 10-17 y in 51%, and $18 y in 35% of cases.
Mean s-25(OH)D was higher in cases, whereas there was no difference in serum retinol. When analyzing all cases and controls, we showed a positive association between s-25(OH)D and risk of prostate cancer ( Table 2) . However, in predefined analyses stratified by season Table 1 under "Supplemental data" in the online issue). As illustrated in Figure 1 , the distribution of s-25(OH)D in cases with serum collected during summer and autumn was skewed to the right, with more cases with high and fewer cases with low concentrations compared with those of controls. For cases with serum collected during winter and spring, distributions were overlapping. Adjustment for educational level did not substantially change the estimates (Table 2 ) and neither did additional adjustment for physical activity, BMI, and smoking (data not shown).
Altogether, 926 cases (44%) were diagnosed with localized disease, 371 cases (18%) were diagnosed with advanced stage, and stage information was unknown for 809 cases (38%). Subgroup analyses revealed no relation between s-25(OH)D and localized prostate cancer ( Table 3) . In contrast, a positive relation was suggested for advanced prostate cancer but only in subjects who were examined during summer and autumn. However, because of the limited number of cases in the latter subgroup, the CI was wide.
Educational level was strongly related to localized, but not advanced, prostate cancer ( Table 4) . There was no consistent difference in the relation between s-25(OH)D and risk of prostate cancer when stratified by length of time between serum sampling and cancer diagnosis, age at diagnosis, or year of diagnosis ( Table 5) .
Stratified analyses were performed according to the 3 geographic regions of Norway. For subjects with serum collected during summer and fall, the positive association between s-25(OH)D and cancer risk was consistent in the southern (RR: 1.25; 95% CI: 1.04, 1.50), middle (RR: 1.34; 95% CI: 0.92, 1.96), and northern regions (RR: 1.37; 95% CI: 0.91, 2.05) per 30-nmol/L increase. Serum retinol was not related to risk of prostate cancer ( Table 6) , and no indication of an interaction between retinol and s-25(OH)D was observed (P-interaction = 0.43).
DISCUSSION
We showed a positive relation between increasing s-25(OH)D and risk of prostate cancer in a large nested case-control study. Neither age at diagnosis nor length of time between blood sampling and diagnosis influenced the relation. However, a predefined subgroup analysis revealed that an even stronger relation was present in subjects with serum collected during summer or autumn, whereas no relation was observed in subjects with serum collected during winter or spring.
A strength of this study was the ability to prospectively follow a large group of men who participated in health survey, performed in the general Norwegian population with respect to a diagnosis of prostate cancer. Since 1953, all malignant diagnoses have been registered compulsory by law in the Cancer Registry of Norway, which ensures high quality and completeness (18) . We were able to follow these men for a long time (#25 y), which allowed us to study whether the time between serum collection and diagnosis influenced the relation between s-25(OH)D and prostate cancer. In contrast, we had limited ability to differentiate by stage of disease, and we had no Gleason grading available. Another weakness was that we only had a single measurement of s-25(OH)D from each participant. However, in the populationbased Tromsø study, s-25(OH)D was measured twice 14 y apart (15) . For subjects reexamined during the same season, the correlation coefficient for s-25(OH)D was 0.52, and 79% of participants had a change ,20 nmol/L during the 14 y (19) . In a Swedish study that used the same laboratory for analyzing s-25(OH)D as we used in this study, the correlation was 0.5 for measurements 11 y apart (20) .
No association between levels of s-25(OH)D and cancer risk was observed for subjects with serum collected during winter and spring, in agreement with the 2 recent meta-analyses that reported no clear relation between s-25(OH)D and risk of prostate cancer (7, 8) . However, the results for subjects with serum collected during summer/autumn indicated a positive association. A previous Nordic study, in which two-thirds of cases were Norwegians, also reported increased risk in subjects with high s-25(OH)D, although an analysis stratified on season was not presented (11) . A Finnish study from 2011, which included 1000 case-control pairs, also reported a positive association between s-25(OH)D and risk of prostate cancer (13) . However, the study did not find any clear difference between subjects examined during sunny and less-sunny months. The only significant association in the season-stratified analysis was an OR of 1.7 in the highest compared with lowest quintiles of 25(OH)D in subjects examined during May through October. In a large, American, nested casecontrol study, higher 25(OH)D was associated with increased risk of aggressive prostate cancer but not with nonaggressive disease (12) . Also, in the Finnish study, a stronger association was suggested in subjects with aggressive disease (13) . These findings are in agreement with our finding of no relation with localized cancer.
Sun exposure and estimated UV radiation significantly predict 25(OH)D concentrations, even at the northernmost latitudes in Norway, which give higher vitamin D concentrations during summer months (21) . Sun exposure is expected to be of great importance for the concentration of 25(OH)D during summer and autumn, whereas dietary and supplementary intakes gain importance during winter and spring because of insufficient UV radiation. Possible confounding factors associated with sun exposure and diet might differ, and this possibility was the rationale for analyses stratified by season. The current results suggested that increased risk of prostate cancer with increasing s-25(OH)D concentrations in cases with serum collected during summer and autumn were related to sun exposure rather than to diet or supplements.
We can only speculate on the causes for the associations observed. Higher s-25(OH)D might be associated with an increased detection rate of prostate cancer. Nonorganized screening with prostate-specific antigen has frequently been used in Norway since the early 1990s. In accordance with this, we showed that risk of prostate cancer was 50% higher in subjects with education at the university level than in subjects with basic education. The relation was even stronger for localized prostate cancer, whereas no clear association between educational level and advanced cancer was observed, which supported the idea of higher diagnostic intensity in higher socioeconomic classes. In contrast, there was no relation between s-25(OH)D and risk of a localized cancer. In addition, adjustment for education did not influence the association between s-25(OH)D and cancer risk. These results suggested that the relation in our study was not explained by an increased detection rate, although such a possibility could not be excluded because education is only a proxy.
Moreover, s-25(OH)D might be a marker of other factors that affect risk of prostate cancer. In this respect, insulin-like growth factor-1 has been related to prostate cancer (22) (23) (24) , and a relation between s-25(OH)D and insulin-like growth factor-1 has been reported (25) . In addition, a high dietary intake of calcium suppresses the formation of 1,25(OH) 2 D and is judged to be a probable risk factor for prostate cancer (24) . However, the dietary intake of calcium is not known to differ during the summer and autumn and winter and spring and is, therefore, not likely to explain the observations in the current study.
Finally, the vitamin D endocrine system might act on the initiation or progression of prostate cancer. We were intrigued that we observed a positive association between s-25(OH)D in subjects with serum collected during summer and autumn and not in subjects with serum collected during winter and spring. Also, during winter and spring, a substantial portion of subjects had s-25(OH)D concentrations .70 nmol/L without having increased risk of prostate cancer. Vieth (26, 27) suggested that, at high latitudes, men with the highest summer 25(OH)D will experience the greatest decline during the fall and winter and suffer a prolonged phase with inadequate prostate-generated 1,25(OH) 2 D, and such large annual fluctuations could potentially explain the findings in our cohort. However, Scandinavian studies have reported that persons with high s-25(OH)D during the summer also had higher concentrations during the next winter compared with subjects who had lower concentrations during the summer (ie, they kept their ranking) (21, 28) . Therefore, it was surprising that the relation between s-25(OH)D and prostate cancer was absent during winter and spring. It is possible to speculate that increased risk was present in subjects with extralarge fluctuation between summer and winter concentrations. Concerning seasonal variations, substantial seasonal differences in 25(OH)D heritability were shown in a Swedish twin study (29) and an American twin study (30) . However, whereas the Swedish study only showed that variability in 25(OH)D was attributed to genetic factors during summer, the American study showed a heritable effect during winter only. High concentrations of retinol may antagonize the effect of vitamin D (2) , and in the Finnish study, an interaction between 25(OH)D and retinol was suggested with a stronger positive relation between s-25(OH)D and prostate cancer in men with low serum retinol (13) . For the active vitamin D metabolite to exert its biologic effect, VDRs must form a complex with the receptor for vitamin A (retinoid X receptor) (31) . Thus, retinol and 1,25(OH) 2 D, via the retinoic acid receptor and VDRs, compete for retinoid X receptor. A high concentration of vitamin A might dissociate the VDR-retinoid X receptor complex (32) . However, we showed no relation between retinol and risk of prostate cancer, and no interaction between s-25(OH)D and retinol on risk of prostate cancer was observed, in line with a recent British study (33) .
In conclusion, our results for the winter and spring group support the results from recent meta-analyses, showing no relation between s-25(OH)D and risk of prostate cancer. The increased risk related to high concentrations during summer and autumn cannot easily be explained. It could indicate other factors that affect risk of prostate cancer but might also reflect large annual fluctuations in s-25(OH)D, which is hypothesized to increase risk of prostate cancer. Moreover, summer and autumn s-25(OH)D can be a better indicator of long-term vitamin D concentrations because it is predominately affected by UV radiation. 
